To detect whether the CB-5083-resistant AML cells might harbor mutations in VCP, we isolated genomic DNA, amplified the relevant DNA regions by PCR and analyzed the sequence by Sanger DNA sequencing. The gene discussed is VCP; the disease is acute myeloid leukemia.